In addition, they found that RAGE and adiponectin receptors (AdipoR1) could be involved in CRC, which concluded that AdipoR2 and GLO-I appeared as novel independent prognostic biomarkers for patients at early disease stage (76). This evidence concerns the gene AGER and colorectal carcinoma.